BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Penn Engineering Events - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Penn Engineering Events
X-ORIGINAL-URL:https://seasevents.nmsdev7.com
X-WR-CALDESC:Events for Penn Engineering Events
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220124T120000
DTEND;TZID=America/New_York:20220124T130000
DTSTAMP:20260406T072814
CREATED:20220121T221747Z
LAST-MODIFIED:20220121T221747Z
UID:6101-1643025600-1643029200@seasevents.nmsdev7.com
SUMMARY:BE Seminar: "Visualizing the Unseen: Enabling Precision Oncology Through Microenvironment-Triggered Diagnostics and Therapeutics" (Liangliang Hao)
DESCRIPTION:The successful integration of precision diagnostics with new personalized therapies opens numerous doors to improve the management of a variety of diseases. In cancer\, tissue-environmental features of tumor progression and invasion\, including aberrant extracellular matrix remodeling\, stromal composition changes\, and immune cell engagement\, create engineering opportunities for use in developing novel biomarkers and therapeutic targets. In this seminar\, I will focus on an emerging paradigm in precision diagnostics: synthetic biomarkers. These bioengineered sensors harness microenvironment-dependent activation mechanisms to generate molecular reporters that can be read out in biofluids. To overcome the limitations often associated with molecular disease biomarkers (cross-reactivity with healthy tissues\, dilution in biofluids below detectable levels\, and rapid degradation of released material)\, I have engineered next-generation synthetic biomarker platforms with enhanced specificity and clinical actionability by 1) developing CRISPR-Cas-amplifiable urinary reporters to detect and differentiate disease states at the point-of-care; 2) advancing theranostic technologies to precisely target the hallmarks of cancer metastasis in specific tissues; 3) improving noninvasive in vivo imaging capabilities to allow for rapid assessment of disease status and interventional efficacy over time. Collectively\, these studies highlight the use of chemical tools with built-in cancer-reactive modules\, embracing a vision for precision health through integrated strategies: identification/monitoring\, imaging\, and intervention in a personalized manner. 
URL:https://seasevents.nmsdev7.com/event/be-seminar-visualizing-the-unseen-enabling-precision-oncology-through-microenvironment-triggered-diagnostics-and-therapeutics-liangliang-hao/
LOCATION:Raisler Lounge (Room 225)\, Towne Building\, 220 South 33rd Street\, Philadelphia\, PA\, 19104\, United States
CATEGORIES:Seminar
END:VEVENT
END:VCALENDAR